相关实验视频

Updated: Jun 25, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

血p-217tau在神经疾病中的临床验证

Takeshi Kawarabayashi^1,2,3, Takumi Nakamura², Ryoma Takahashi²

¹Department of Neurology, Dementia Research Center, Geriatrics Research Institute and Hospital, Maebashi, Japan.

Annals of clinical and translational neurology

|March 9, 2026

概括

血p-217tau对阿尔茨海默病 (AD) 诊断有前途,但在其他神经疾病 (如ALS和iNPH) 中的特异性较低. 为了可靠的临床应用,需要进一步验证.

科学领域:

神经学神经学
生物标志物发现发现
神经退行性疾病神经退行性疾病

背景情况:

血p-217tau是阿尔茨海默病 (AD) 的一个有希望的生物标志物.
它在各种神经疾病中的诊断特异性需要彻底的临床评估.
了解潜在的混因素对于准确的AD诊断至关重要.

研究的目的:

为了验证血p-217tau.tau的诊断可靠性和特异性.
评估血p-217tau在区分AD与其他12种神经疾病方面的表现.
为了确定血p-217tau.tau.在临床应用中的潜在陷.

主要方法:

在298名参与者身上测量了血p-217tau水平,包括阿尔茨海默病患者,其他12种神经疾病患者和健康对照组.
在特定患者组 (AD,ALS,iNPH) 中分析了脑脊液 (CSF) 的tau和Aß水平.
来自Meso Scale Diagnostics的测试系统被用于血p-217tau的测量.

主要成果:

血p-217tau水平在阿尔茨海默病患者中升高,也在肌缩侧面硬化症 (ALS) 和异常正常压力脑症 (iNPH) 患者中升高.
这种升高降低了血p-217tau的灵敏度和特异性,用于在ALS和iNPH存在时诊断AD.
在AD中观察到CSF和血p-217tau之间的强烈相关性,但在ALS中没有,在ALS中血/CSF比率较高.

结论:

肌缩侧面硬化症 (ALS) 和异常性正常压力脑症 (iNPH) 对于使用血p-217tau作为AD生物标志物构成重大挑战.
在ALS中血p-217tau水平升高与下部运动神经元损伤有关.
在iNPH中,血p-217tau升高与认知功能障碍有关,而不是步态或尿路问题.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.骨髓缩侧面硬化症 (ALS) 是一种异常性正常压力水脑.血中的p-tau.在p-tau217

更多相关视频

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

相关概念视频

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...